Rory B. Riggs - 18 Jun 2019 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ John P. Condon, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
18 Jun 2019
Net transactions value
$0
Form type
4
Filing time
15 Oct 2024, 18:00:03 UTC
Next filing
11 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise +14,189 +12% 131,297 18 Jun 2019 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Options Exercise $0 -14,189 -100% $0.000000 0 18 Jun 2019 Common Stock 14,189 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On June 18, 2018, the reporting person was granted 14,189 restricted stock units, vesting on the first anniversary of the grant date (June 18, 2019).

Remarks:

This Form 4 is being filed to report the vesting on June 18, 2019 of previously reported restricted stock units. This transaction is being reported late due to an inadvertent administrative error.